Arthur Ozeki
Known title: EVP, Head of Asia PacificCIK: 0002005023
Associated companies
Transaction History
| RGA | ▲ Buy | Option Exercise | 2,689 | $551K | 3/12/2026 | View on chart |
| RGA | ▲ Buy | Option Exercise | 232 | — | 1/15/2026 | View on chart |
| RGA | ▲ Buy | Option Exercise | 153 | — | 1/15/2026 | View on chart |
| RGA | ▲ Buy | Option Exercise | 576 | — | 1/15/2026 | View on chart |
| RGA | ▲ Buy | Grant | 3,520 | $655K | 3/14/2025 | View on chart |
| RGA | ▲ Buy | Option Exercise | 891 | — | 1/16/2025 | View on chart |
| RGA | ▲ Buy | Option Exercise | 153 | — | 1/16/2025 | View on chart |
| RGA | ▲ Buy | Option Exercise | 459 | — | 1/18/2024 | View on chart |
| RGA | ▲ Buy | Grant | 892 | $150K | 1/18/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
RGA Faces Positive Outlook Amid Strong Annuity Demand
Reinsurance Group of America is drawing attention from analysts who cite medical and rate tailwinds as drivers for potential upside. The company is also benefiting from strong demand for annuities, a trend shared by other major life insurers. While higher Treasury yields are reshaping the broader insurance sector, RGA’s valuation metrics, including a trailing P/E of 10.7, remain in focus for value-oriented observers.
RGA Faces Positive Outlook Amid Strong Annuity Demand. Reinsurance Group of America is drawing attention from analysts who cite medical and rate tailwinds as drivers for potential upside. The company is also benefiting from strong demand for annuities, a trend shared by other major life insurers. While higher Treasury yields are reshaping the broader insurance sector, RGA’s valuation metrics, including a trailing P/E of 10.7, remain in focus for value-oriented observers.